Chateal Eq Kit
Product Images NDC 50102-230

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Chateal Eq (NDC 50102-230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Levo Ethi Fig1)

Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Levo Ethi Fig1)
This text appears to be a table showing various categories and ranges for pregnancy and blood clots among women who are not pregnant, not using COC (a type of birth control pill), or postpartum (up to 12 weeks after giving birth). The table provides information on the number of women with a blood clot out of 10,000 women years (WY) in each category, but the specific data is not entirely clear due to formatting and missing values. Additionally, there is a note regarding pregnancy data that is based on actual duration of pregnancy for reference studies.*
FDA Label Image

Figure-2 (Levo Ethi Fig2)

Figure-2 (Levo Ethi Fig2)
This text provides information about the results of different studies on the association between using Combined Oral Contraceptives (COC) and different health outcomes. The studies present the Odds Ratio (OR), Relative Risk (RR) or Hazard Ratio (HR) and the confidence intervals for different comparisons, such as Ever COC vs. Never COC use or Current COC use vs. Never-use. The studies evaluate the association with outcomes such as women's health, sex hormones, and other medical conditions.*
FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (28 Tablets Pouch))

Package Label-principal Display Panel (0.15 mg/0.03 mg (28 Tablets Pouch))
This appears to be a chart comparing various methods of birth control and their effectiveness at preventing pregnancy. The chart shows the number of pregnancies per 100 women that can be expected in one year when using different forms of birth control, ranging from fewer than 1 pregnancy per 100 women for the most effective methods such as implants and sterilization, up to 85 or more pregnancies per 100 women for no birth control at all. Different methods of birth control are listed, including hormonal methods (pills, patches, injections, vaginal rings), barrier methods (condoms, diaphragms), fertility awareness methods (avoiding sex during fertile days), and withdrawal.*
FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (84 Tablets Carton))

Package Label-principal Display Panel (0.15 mg/0.03 mg (84 Tablets Carton))
This text is a label for a product that encourages the user to store it under controlled temperature. The product name is Orange, and there is a mention of a Green color and a Figure A, which may be related to the product. Additionally, there is a table with the days of the week and a line with illegible characters. Overall, the text provides limited information and context.*
FDA Label Image

Levo Ethi Fig5

Levo Ethi Fig5
FDA Label Image

Levo Ethi Fig6

Levo Ethi Fig6
FDA Label Image

Levo Ethi Str1

Levo Ethi Str1
The text is not useful since it only provides chemical formula and molecular weight of Levonorgestrel.*
FDA Label Image

Levo Ethi Str2

Levo Ethi Str2
Description not-available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.